Literature DB >> 7126404

Dural permeability to narcotics: in vitro determination and application to extradural administration.

R A Moore, R E Bullingham, H J McQuay, C W Hand, J B Aspel, M C Allen, D Thomas.   

Abstract

The permeability of cranial and lumbar dura to various substances including a number of narcotic analgesics was measured in vitro. Preliminary data On human postmortem material is reported. Permeability had a linear relation to the inverse of the square root of molecular weight. This is the expected relationship for a diffusion process dependent upon molecular weight. The differential mass selectivity coefficients for lumbar and cranial dura were calculated; they were similar at 0.8 and 0.9. This was greater than for diffusion in simple liquids, but much less than that for biological lipid membranes. This suggests that the low rates of diffusion are a property of the thickness of the dura rather than any inherent impermeability. A simple model for the dural transfer of drugs is described, and applied to narcotics. Its purposes were to suggest: the factors involved in the dural transfer of drugs; the physicochemical properties of drugs relevant to their dural transfer; worthwhile measurements in future studies. The model indicates that drug molecular weight and rate of absorption are important determinants of the efficiency of dural transfer. Low molecular weight and slow absorption produce high dural transfers. When applied to narcotics, these factors could produce a difference of up to an order of magnitude in the amount transferred directly across the dura.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7126404     DOI: 10.1093/bja/54.10.1117

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  18 in total

Review 1.  The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.

Authors:  D P Beltrutti; S Moessinger; G Varrassi
Journal:  Curr Rev Pain       Date:  2000

2.  Spinal disposition and meningeal permeability of local anesthetics.

Authors:  Rozenn Clément; Jean-Marc Malinovsky; Patrice Hildgen; Gilles Dollo; Jean Pierre Estèbe; François Chevanne; Roger Le Verge; Pascal Le Corre
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

3.  Dissociation between CSD-Evoked Metabolic Perturbations and Meningeal Afferent Activation and Sensitization: Implications for Mechanisms of Migraine Headache Onset.

Authors:  Jun Zhao; Dan Levy
Journal:  J Neurosci       Date:  2018-04-27       Impact factor: 6.167

4.  Epidural administered buprenorphine in the perioperative period.

Authors:  Y Miwa; E Yonemura; K Fukushima
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

5.  Cranial dural permeability of inflammatory nociceptive mediators: Potential implications for animal models of migraine.

Authors:  Jun Zhao; Dara Bree; Michael G Harrington; Andrew M Strassman; Dan Levy
Journal:  Cephalalgia       Date:  2016-08-19       Impact factor: 6.292

6.  Comparison of bupivacaine and fentanyl as an adjuvant of epidural morphine for postoperative analgesia.

Authors:  Makoto Tanaka; Seiji Watanabe; Hiroshi Naito
Journal:  J Anesth       Date:  1994-06       Impact factor: 2.078

7.  In vitro determination of human dura mater permeability to opioids and local anaesthetics.

Authors:  R F McEllistrem; R G Bennington; S H Roth
Journal:  Can J Anaesth       Date:  1993-02       Impact factor: 5.063

8.  Laminectomy-induced arachnoradiculitis: a postoperative serial MRI study.

Authors:  H Matsui; H Tsuji; M Kanamori; Y Kawaguchi; K Yudoh; R Futatsuya
Journal:  Neuroradiology       Date:  1995-11       Impact factor: 2.804

9.  The pharmacokinetics of intradural morphine in major abdominal surgery.

Authors:  T I Ionescu; R H Drost; J M Roelofs; E K Winckers; R H Taverne; A A van Maris; J M van Rossum
Journal:  Clin Pharmacokinet       Date:  1988-03       Impact factor: 6.447

Review 10.  Newer methods of delivery of opiates for relief of pain.

Authors:  P J Slattery; R A Boas
Journal:  Drugs       Date:  1985-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.